Elżbieta Katarzyna Biernacka, Piotr Kułakowski, Agnieszka Sikorska
{"title":"Extreme prolongation of QTU in a patient with Andersen-Tawil sydrome.","authors":"Elżbieta Katarzyna Biernacka, Piotr Kułakowski, Agnieszka Sikorska","doi":"10.33963/v.phj.106747","DOIUrl":"https://doi.org/10.33963/v.phj.106747","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Piotr Niewiński, Stanisław Tubek, Krzysztof Nowak, Krystian Josiak, Piotr Brzozowski, Piotr Ponikowski
{"title":"Partial restitution of parasympathetic reactivity of sinus node one year following cardioneuroablation: Results from a pilot study.","authors":"Piotr Niewiński, Stanisław Tubek, Krzysztof Nowak, Krystian Josiak, Piotr Brzozowski, Piotr Ponikowski","doi":"10.33963/v.phj.106735","DOIUrl":"https://doi.org/10.33963/v.phj.106735","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Subclinical atrial fibrillation: Who benefits from oral anticoagulation?","authors":"Dan Atar, Cecilia Linde","doi":"10.33963/v.phj.106733","DOIUrl":"https://doi.org/10.33963/v.phj.106733","url":null,"abstract":"<p><p>The value of anticoagulation to prevent embolic strokes in subclinical atrial fibrillation detected by implantable cardiac devices has not been established. Recently, two randomized controlled studies scrutinized whether such patients benefit from oral anticoagulation to prevent embolic strokes. These two studies were the NOAH-AFNET-6 (Anticoagulation with Edoxaban in patients with atrial high-rate episodes) trial and the ARTESIA (Apixaban for stroke prevention in subclinical atrial fibrillation) study but separately came to different conclusions using different primary endpoints. While the investigators of NOAH-AFNET-6, based on a composite primary endpoint, concluded that no patient with device-detected AF should be anticoagulated, the ARTESIA investigators demonstrated overall value of anticoagulation based on stroke/systemic embolism as sole endpoint. However, the main question for subclinical atrial fibrillation patients is to which extent stroke and thromboembolism can be prevented by anticoagulation and weighing such a benefit to the risk of major bleeding. After initial confusion a meta-analysis of both studies focusing on the endpoint \"ischemic stroke\" and \"all-cause stroke\" revealed an overall superiority of anticoagulation against placebo/aspirin therapy. The combined evidence did in the end inform the cardiovascular community of the superiority of anticoagulation but confined to those with high risk i.e. CHA₂DS₂-VASc score >4, particularly in those with any type of vascular disease. The meta-analysis also revealed that no anticoagulation is indicated in patients with CHA₂DS₂-VASc score <4, and with shared decision making recommended for those with CHA₂DS₂-VASc score of = 4. It is reassuring that despite a first impression of diverging results of the major two trials, a meta-analysis helped to clarify the uniformity and consistency of the results across the studies, which will help physicians and nurses in their daily care of patients with implantable devices.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Szymon Warwas, Ewa Jędrzejczyk-Patej, Oskar Kowalski, Adam Sokal, Sławomir Pluta, Wiktoria Kowalska, Michał Mazurek, Radosław Lenarczyk, Zbigniew Kalarus, Beata Średniawa
{"title":"Quality of life in patients with a leadless pacemaker versus transvenous pacemaker.","authors":"Szymon Warwas, Ewa Jędrzejczyk-Patej, Oskar Kowalski, Adam Sokal, Sławomir Pluta, Wiktoria Kowalska, Michał Mazurek, Radosław Lenarczyk, Zbigniew Kalarus, Beata Średniawa","doi":"10.33963/v.phj.106688","DOIUrl":"https://doi.org/10.33963/v.phj.106688","url":null,"abstract":"<p><strong>Background: </strong>The transvenous pacemaker (PM) is a well-accepted device for advanced atrioventricular block and sick sinus syndrome, but it is associated with complications. Leadless pacemakers (LPM) offer a solution by eliminating transvenous leads and PM pocket, potentially improving outcomes. However, the impact of LPM on quality of life (QoL) remains understudied.</p><p><strong>Aims: </strong>To compare QoL of patients with leadless versus transvenous PMs.</p><p><strong>Material and methods: </strong>Single-center prospective study included all comers with LPMs implanted between January 2016 and March 2022. A cohort of transvenous PM patients was matched to LPM subjects by age, sex, left ventricle ejection fraction, heart failure, atrial fibrillation and indication for the device implantation. All patients were requested to complete two standardized questionnaires: the 36-Item Short-Form Health Survey (SF-36) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) 12 months after device implantation.</p><p><strong>Results: </strong>Patients with LPMs (n = 31) and matched transvenous PM group (n = 31) did not differ regarding baseline characteristics. The median MLHFQ total score was 33.5 (0-88) for LPM and 21 (3-68) for PM group (P = 0.80). The median total score for the SF-36 questionnaire was 54 (8-140) vs. 35 (14-105) for LPM and PM, respectively (P = 0.86). No differences were found between leadless and transvenous PM subgroups, both for mental and physical QoL assessed in MLHFQ (6 [2-9.5] vs. 2 [0-6]; P = 0.08; 9.5 [2-19] vs. 7 [1-12]; P = 0.52, respectively) and in domains of SF-36.</p><p><strong>Conclusions: </strong>QoL after device implantation does not differ between patients with leadless and transvenous PMs.</p>","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paweł Gąsior, Radosław Liszka, Marta Bujak, Joanna Kidoń, Mariusz Gąsior, Dariusz Dudek, Maciej Wybraniec, Tomasz Skowerski, Krzysztof Wilczek, Janusz Szkodziński, Wojciech Wojakowski, Krzysztof Dyrbuś
{"title":"The R-One robotic system for percutaneous coronary intervention: Insights from the Robo-SIL Registry.","authors":"Paweł Gąsior, Radosław Liszka, Marta Bujak, Joanna Kidoń, Mariusz Gąsior, Dariusz Dudek, Maciej Wybraniec, Tomasz Skowerski, Krzysztof Wilczek, Janusz Szkodziński, Wojciech Wojakowski, Krzysztof Dyrbuś","doi":"10.33963/v.phj.106701","DOIUrl":"https://doi.org/10.33963/v.phj.106701","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144285134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Olasińska-Wiśniewska, Tomasz Urbanowicz, Paweł Gutaj, Jan Matysiak, Szymon Plewa, Beata Krasińska, Martyna Pakuła-Iwańska, Andrzej Tykarski, Antonios Chalapas, Marek Jemielity, Ewa Wender-Ożegowska
{"title":"Lysophosphatidylcholine as a biomarker for severe aortic stenosis in diabetic patients: Preliminary report.","authors":"Anna Olasińska-Wiśniewska, Tomasz Urbanowicz, Paweł Gutaj, Jan Matysiak, Szymon Plewa, Beata Krasińska, Martyna Pakuła-Iwańska, Andrzej Tykarski, Antonios Chalapas, Marek Jemielity, Ewa Wender-Ożegowska","doi":"10.33963/v.phj.106620","DOIUrl":"https://doi.org/10.33963/v.phj.106620","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wojciech Wróbel, Marek Elżbieciak, Marek Grabka, Radosław Gocoł, Damian Hudziak, Katarzyna Mizia-Stec
{"title":"Unraveling the thread: Treating a left-to-right shunt with aorto-coronary bypass grafting.","authors":"Wojciech Wróbel, Marek Elżbieciak, Marek Grabka, Radosław Gocoł, Damian Hudziak, Katarzyna Mizia-Stec","doi":"10.33963/v.phj.106614","DOIUrl":"https://doi.org/10.33963/v.phj.106614","url":null,"abstract":"","PeriodicalId":17784,"journal":{"name":"Kardiologia polska","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}